What a difference a day makes. Black Friday turned into Red Friday after the pandemic took a new turn for the worse.
Is it déjà vu all over again? Do we have control over COVID-19, or does the coronavirus have control over us?
The narrative for the pandemic finally coming to an end just went south, and with it, short-term investor sentiment. The market doesn’t trade well against heightened levels of uncertainty, including all the protocols, mandates, restrictions and new forms of vaccines coming at a time when investors were increasing equity exposure into what was shaping up to be a very bullish close to 2021.
Source: Bloomberg.com, Nov. 28, 2021
World governments are taking swift action against the newly discovered Omicron COVID-19 strain that is already popping up in other countries outside South Africa, where it first emerged. Dr. Fauci believes it inevitably will be in the United States, and may already be present, just not yet reported. Looking at Bloomberg headlines over the weekend:
WHO Warns of ‘No Information’ on Severity of Omicron
Airlines Scramble as Restrictions Return
NYC May Be at Start of Winter Surge
Swiss Vote to Keep Covid Health Pass
Botswana Identifies More Cases
Fauci Stresses Need for Vaccination
Germany Has More Suspected Omicron Cases
Dutch Cluster Suggests Omicron Foothold in Europe
Moderna Vaccine for Omicron May be Ready in 2022
Merck Covid Pill Set for Authorization Despite Concerns, MS Says
Given the World Health Organization (WHO) taking its usual wait and see approach, claiming it doesn’t have enough information to come to any near-term conclusions or action plan, it suggests to me that the market will remain in flux until much more is known about the new variant. The only thing the WHO has made its mind up on is what name to call it — NU, for new virus. How about WU — for Wuhan?
So, now the market has to contend with inflationary pressures and what is likely to be an array of anti-COVID measures that could stifle growth heading into 2022. This being a growing likelihood scenario, it stands to reason that capital flows targeting income generation will increase into short-term corporate bonds and into equities of companies in stay-at-home, telecom, consumer staples, utilities, health care and real estate.
Sources of funds, at least over the very short term, will be energy, financials, consumer discretionary, industrials, materials, metals and mining. Once the smoke clears from the initial wave of selling, technology stocks should recoup most of their losses, as that sector led the market to new highs every time there was a COVID-flareup-related sell-off, and there is little evidence to suggest this will be different going forward.
A couple observations should be noted that will continue to characterize the market landscape. The first is that the strong dollar will likely get stronger as investors seek safety in dollar-denominated assets. The greenback was hit by sellers on Friday as knee-jerk logic kicked in and the Fed’s plan to taper would now be put on hold. The dollar index (DXY) was clearly overbought, but will probably find strong support at the $94.00 level, roughly 2% below where it closed Friday.
A strong dollar is a negative force for multinational corporations that conduct more than 50% of sales outside the United States. Hence, fourth-quarter profits are likely to reflect the impact of foreign exchange (forex) headwinds and pinch S&P 500 earnings growth forecasts for Q4 2021 and Q1 2022. On the plus side, oil prices tumbled last week, with WTI crude ending Friday’s session down 13.06% to $68.15/bbl. Natural gas was unaffected, closing up 7.1% to $5.48/MBtu as shortages in Europe heading into winter are providing a strong bid.
Here, too, investors seeking inflation-hedged income should look at some of the natural gas producers and pipeline operators that are pure plays on natural gas, as this is where strong fundamentals exist for U.S. energy companies with domestic operations serving domestic markets that won’t have their profits impacted by a strong dollar. What was the growingly attractive global reflation trade is now rapidly reverting to the hunker down local and regional economy trade, at least until the U.S. Centers for Disease Control and Prevention (CDC) gives the “all clear” sign. That signal, sadly, is probably several weeks or a few months off.